Company Filing History:
Years Active: 2021-2025
Title: Yi-Ting Kuo: Innovator in Immunotherapy
Introduction
Yi-Ting Kuo is a prominent inventor based in Taichung, Taiwan. She has made significant contributions to the field of immunotherapy, particularly through her work on anti-interferon gamma antibodies. With a total of 2 patents, her innovations are paving the way for new treatments in medicine.
Latest Patents
Yi-Ting Kuo's latest patents focus on anti-interferon gamma antibodies and their applications. The first patent provides an anti-INF-γ antibody, along with a composition that includes the antibody and a pharmaceutical application aimed at treating IFN-γ mediated syndrome. The second patent reiterates this innovation, emphasizing the importance of the anti-INF-γ antibody in therapeutic contexts.
Career Highlights
Kuo is currently associated with Elixiron Immunotherapeutics (Hong Kong) Limited, where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against diseases mediated by interferon gamma.
Collaborations
Some of her notable coworkers include Cheng-Lun Ku and Han-Po Shih, who contribute to her research endeavors and collaborative projects.
Conclusion
Yi-Ting Kuo's innovative work in the field of immunotherapy highlights her role as a leading inventor. Her patents on anti-interferon gamma antibodies represent significant advancements in medical treatments.